Quick Search:

uzh logo
Browse by:
bullet
bullet
bullet
bullet

Zurich Open Repository and Archive

Hermann, M; Ruschitzka, F (2009). The hypertension peril: lessons from CETP inhibitors. Current Hypertension Reports, 11(1):76-80.

Full text not available from this repository.

View at publisher

Abstract

Pharmacologic inhibitors of the cholesteryl ester transfer protein (CETP) are capable of increasing HDL cholesterol by 50% to 100% in humans. Despite intriguing antiatherogenic effects of CETP inhibition in animal models of atherosclerosis, the Investigation of Lipid Level Management to Understand its Impact in Atherosclerotic Events trial investigators observed an excess of cardiovascular and noncardiovascular morbidity and mortality associated with the use of the CETP inhibitor torcetrapib. This review summarizes available clinical and experimental data about potential underlying mechanisms.

Citations

3 citations in Web of Science®
4 citations in Scopus®
Google Scholar™

Altmetrics

Downloads

0 downloads since deposited on 06 Apr 2009
0 downloads since 12 months

Additional indexing

Item Type:Journal Article, refereed, original work
Communities & Collections:04 Faculty of Medicine > University Hospital Zurich > Clinic for Cardiology
DDC:610 Medicine & health
Language:English
Date:February 2009
Deposited On:06 Apr 2009 13:03
Last Modified:28 Nov 2013 00:39
Publisher:Springer
ISSN:1522-6417
Publisher DOI:10.1007/s11906-009-0014-9
PubMed ID:19146805

Users (please log in): suggest update or correction for this item

Repository Staff Only: item control page